| Dr Eric M Behling, MD | |
|
1 Cooper Plz, Dept. Of Pathology, Camden, NJ 08103-1461 | |
| (856) 342-2506 | |
| (856) 968-8312 |
| Full Name | Dr Eric M Behling |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 24 Years |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831125517 | NPI | - | NPPES |
| 101650011 | Medicaid | PA | |
| 01016241 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper Pathology Pc | 3375569577 | 25 |
News Archive
GlaxoSmithKline PLC said it will pay the U.S. government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo marketed some drugs illegally and defrauded the Medicaid program. The settlement will also cover a Department of Justice probe into Glaxo's development and marketing of the diabetes drug Avandia, which has been linked to heart attack risks.
Researchers at Brigham and Women's Hospital have found two new potential drug targets for treating arterial diseases such as atherosclerosis.
News outlets report on a pair of studies related to Medicare populations. The first concludes that the odds for a Medicare patient surviving a complex surgery are improving. Meanwhile, a second study found that better informed patients have lower costs, do better managing their medications and can slow the rate of readmissions.
UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.
› Verified 2 days ago
| Entity Name | Cooper Pathology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720023583 PECOS PAC ID: 3375569577 Enrollment ID: O20051018000031 |
News Archive
GlaxoSmithKline PLC said it will pay the U.S. government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo marketed some drugs illegally and defrauded the Medicaid program. The settlement will also cover a Department of Justice probe into Glaxo's development and marketing of the diabetes drug Avandia, which has been linked to heart attack risks.
Researchers at Brigham and Women's Hospital have found two new potential drug targets for treating arterial diseases such as atherosclerosis.
News outlets report on a pair of studies related to Medicare populations. The first concludes that the odds for a Medicare patient surviving a complex surgery are improving. Meanwhile, a second study found that better informed patients have lower costs, do better managing their medications and can slow the rate of readmissions.
UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric M Behling, MD 1 Cooper Plz, Dept. Of Pathology, Camden, NJ 08103-1461 Ph: (856) 342-2506 | Dr Eric M Behling, MD 1 Cooper Plz, Dept. Of Pathology, Camden, NJ 08103-1461 Ph: (856) 342-2506 |
News Archive
GlaxoSmithKline PLC said it will pay the U.S. government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo marketed some drugs illegally and defrauded the Medicaid program. The settlement will also cover a Department of Justice probe into Glaxo's development and marketing of the diabetes drug Avandia, which has been linked to heart attack risks.
Researchers at Brigham and Women's Hospital have found two new potential drug targets for treating arterial diseases such as atherosclerosis.
News outlets report on a pair of studies related to Medicare populations. The first concludes that the odds for a Medicare patient surviving a complex surgery are improving. Meanwhile, a second study found that better informed patients have lower costs, do better managing their medications and can slow the rate of readmissions.
UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.
› Verified 2 days ago
Brendan Fitzpatrick, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 610-459-3113 | |
Hoon Kim, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 610-459-3113 | |
Roland Schwarting, MD Pathology Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2506 Fax: 856-968-8312 | |
William Harrer, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 610-459-3113 | |
Dr. Suad Taraif, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2506 | |
Ruth Carolina Birbe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 | |
Miles M Mcfarland, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2506 Fax: 856-968-8312 |